Cargando…

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches

Introduction: In the era of multidrug-resistant, extensively drug-resistant (XDR) and even pandrug-resistant Gram-negative microorganisms, the medical community is facing the threat of untreatable infections particularly those caused by carbapenemase-producing bacteria, that is, Klebsiella pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karaiskos, Ilias, Giamarellou, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819585/ https://www.ncbi.nlm.nih.gov/pubmed/24766095 http://dx.doi.org/10.1517/14656566.2014.914172

Ejemplares similares

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
por: Giamarellou, Helen, et al.
Publicado: (2022)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
por: Reynolds, Daniel, et al.
Publicado: (2022)

Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae
por: Pitt, Miranda E., et al.
Publicado: (2018)

Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
por: Ruiz Ramos, Jesús, et al.
Publicado: (2019)

Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens
por: Wang, Weijie, et al.
Publicado: (2022)

Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
por: Wang, Yuhang, et al.
Publicado: (2023)

2475. Incidence of Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Gram-Negative Bacteria in Brazilian Intensive Care Units
por: Souza, Gregory Lauar, et al.
Publicado: (2019)

Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens
por: Pybus, Christine A., et al.
Publicado: (2021)

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2021)

Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)

Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
por: Livermore, David M.
Publicado: (2012)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Defining multidrug resistance in Gram-negative bacilli
por: Kumar, V. Anil, et al.
Publicado: (2015)

Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
por: Briers, Yves, et al.
Publicado: (2014)

Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
por: Thomson, Kenneth S., et al.
Publicado: (2019)

Frequency of Extensively Drug-Resistant Gram-Negative Pathogens in a Tertiary Care Hospital in Pakistan
por: Abbas, Sundas, et al.
Publicado: (2020)

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria
por: Watkins, Richard R., et al.
Publicado: (2019)

Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
por: Koh Jing Jie, Augustine, et al.
Publicado: (2022)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?
por: Salmi, Chanaz, et al.
Publicado: (2008)

Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis
por: Mehrotra, Tanshi, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review
por: Abubakar, Usman, et al.
Publicado: (2023)

Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens
por: Kadouri, Daniel E., et al.
Publicado: (2013)

Antibiotic synergy testing for multidrug-resistant Gram-negative pathogens in a Greek ICU
por: Douka, E, et al.
Publicado: (2015)

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens
por: Crawford, Matthew A., et al.
Publicado: (2017)

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens
por: Roberts, Kade D., et al.
Publicado: (2022)

Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis
por: Abushanab, Dina, et al.
Publicado: (2022)

Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review
por: Nørgaard, Sarah Melissa, et al.
Publicado: (2019)

The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities
por: O’Fallon, Erin, et al.
Publicado: (2009)

Prevalence of multidrug-resistant and extensively drug-resistant phenotypes of Gram-negative bacilli isolated in clinical specimens at Centre Hospitalo-Universitaire Ibn Rochd, Morocco
por: Zalegh, Imane, et al.
Publicado: (2023)

Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative Pathogens
por: Hind, Charlotte K., et al.
Publicado: (2019)

Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt
por: El-Kholy, Amani A., et al.
Publicado: (2020)

Prevalence of multidrug resistance, extensive drug resistance and pandrug resistance among multiple Gram-negative isolates: experience in a tertiary-care hospital ICU in North India
por: Dewan, S, et al.
Publicado: (2013)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria
por: Tängdén, Thomas
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l1a50a0ns8bo1rgjtl7m3juohd